Centene Corporation (NYSE:CNC) Shows Bullish Momentum But Near-Term Pullback Risk

Robust cash generation and an EPS beat created constructive momentum, while several technical indicators signal the possibility of short-term consolidation before a sustained move.

Recent News

On June 22, 2026 Centene appointed Lauren M. Tyler to its board of directors. On July 7, 2026 Cantor Fitzgerald raised its price target for Centene citing payor outlook. On July 23, 2026 director Kenneth Burdick notified the company of his resignation effective July 28, 2026.

Technical Analysis

ADX and Directional Indicators — ADX registers 21.19, indicating an emerging trend strength. DI+ shows a peak-and-reversal, which signals bearish directional pressure; DI- sits at 24.57 and trends decreasing, which signals a bullish directional shift. Together these readings produce offsetting directional cues that imply limited conviction until ADX moves decisively higher, so price action may trade in a range near current levels.

MACD — MACD stands at 0.41 with the signal line at 0.32 and the MACD trend increasing; the MACD line sits above its signal line, which represents a bullish momentum crossover. That bullish momentum supports upside continuation toward consensus analyst targets if momentum holds.

MRO (Momentum/Regression Oscillator) — MRO reads 13.66 (positive) and shows a peak-and-reversal. A positive MRO indicates the price sits above its target and faces potential downward pressure; the peak-and-reversal trend raises the near-term probability of a pullback or consolidation before any fresh advance.

RSI and Momentum — RSI sits at 55.24 and trends higher, indicating mild bullish momentum without overbought extremes. That level supports further upside but leaves room for mean-reversion if selling pressure appears.

Price Structure, Averages, and Bands — The last close at $67.07 sits above the 20-day average ($64.26), 50-day average ($64.65), and 200-day average ($47.79), confirming a bullish structural bias. Price trades slightly above the upper 1× Bollinger band ($66.37) and just below the super-trend upper level ($67.12), which places near-term resistance very close to the current market price and raises the chance of a short pause or pullback.

Volume and Volatility — Daily volume at ~3.24M runs below the 10-day average (~4.95M) and the 200-day average (~6.30M), while 42‑ and 52‑week volatilities sit low. The advance shows limited participation, which reduces conviction behind the move and increases sensitivity to negative momentum signals (MRO peak/reversal, DI+ peak).

 


Fundamental Analysis

Top-line and margins — Total revenue reached $53,579,000,000. Trailing revenue growth year-over-year measures 59.89%, with quarter-over-quarter acceleration recorded. Operating income stands at $1,198,000,000 and EBIT at $1,639,000,000, yielding an EBIT margin of 3.06%. EBIT margin contracted about 32.49% quarter-over-quarter and fell about 18.19% year-over-year, reflecting margin pressure despite strong revenue expansion.

Profitability and returns — Net income totaled $1,091,000,000. Return on equity registers 4.84% and return on assets 1.33%, both positive but modest given the company’s scale. Interest coverage remains healthy at roughly 10.71x, while debt-to-EBITDA sits near 8.31x, indicating elevated leverage relative to EBITDA though interest serviceability appears intact.

Cash flow and liquidity — Operating cash flow reached $3,590,000,000 with free cash flow of $3,416,000,000 and a free cash flow yield of 11.49%. Centene carries $24,151,000,000 in cash and $27,057,000,000 in cash and short-term investments, supporting near-term obligations; current ratio registers about 1.15.

EPS and surprises — Reported EPS equals $2.51 versus an estimate of $1.08, a $1.43 beat that represents a 132.41% surprise relative to the estimate. That earnings beat supports a near-term re-rating but does not remove operating-margin trends shown above.

Peer comparisons where available — The EBIT margin at 3.06% sits below the industry peer mean of 7.68% and below the industry peer median of 4.46% while remaining above the industry peer low. Receivables turnover of 2.86 sits below the industry peer mean but within the peer range provided. Use of the industry peer mean and median clarifies where operating margin and efficiency metrics lag or align.

Valuation note — WMDST values the stock as under-valued. Key valuation metrics: market capitalization about $29.73B, enterprise value about $18.77B, enterprise multiple ~9.68, and free cash flow yield ~11.49%. Those cash-flow and multiple metrics underlie the WMDST valuation stance while remaining subject to operating-margin trends and leverage dynamics.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2026-06-30
REPORT DATE: 2026-07-28
NEXT REPORT DATE: 2026-10-27
CASH FLOW  Begin Period Cash Flow 21.4 B
 Operating Cash Flow 3.6 B
 Capital Expenditures -174.00 M
 Change In Working Capital 2.1 B
 Dividends Paid
 Cash Flow Delta 2.9 B
 End Period Cash Flow 24.3 B
 
INCOME STATEMENT REVENUE
 Total Revenue 53.6 B
 Forward Revenue 8.0 B
COSTS
 Cost Of Revenue 49.0 B
 Depreciation 139.0 M
 Depreciation and Amortization 300.0 M
 Research and Development
 Total Operating Expenses 52.4 B
PROFITABILITY
 Gross Profit 4.6 B
 EBITDA 1.9 B
 EBIT 1.6 B
 Operating Income 1.2 B
 Interest Income
 Interest Expense 153.0 M
 Net Interest Income -153.00 M
 Income Before Tax 1.5 B
 Tax Provision 399.0 M
 Tax Rate 26.9 %
 Net Income 1.1 B
 Net Income From Continuing Operations 1.1 B
EARNINGS
 EPS Estimate 1.08
 EPS Actual 2.51
 EPS Difference 1.43
 EPS Surprise 132.407 %
 Forward EPS 1.33
 
BALANCE SHEET ASSETS
 Total Assets 83.0 B
 Intangible Assets 15.0 B
 Net Tangible Assets 7.5 B
 Total Current Assets 46.7 B
 Cash and Short-Term Investments 27.1 B
 Cash 24.2 B
 Net Receivables 18.1 B
 Inventory
 Long-Term Investments 2.9 B
LIABILITIES
 Accounts Payable 18.0 B
 Short-Term Debt 75.0 M
 Total Current Liabilities 40.8 B
 Net Debt
 Total Debt 16.1 B
 Total Liabilities 60.4 B
EQUITY
 Total Equity 22.6 B
 Retained Earnings 11.3 B
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 45.67
 Shares Outstanding 493.987 M
 Revenue Per-Share 108.46
VALUATION
 Market Capitalization 29.7 B
 Enterprise Value 18.8 B
 Enterprise Multiple 9.682
Enterprise Multiple QoQ 113.768 %
Enterprise Multiple YoY -87.636 %
Enterprise Multiple IPRWA high: 87.909
mean: 34.227
median: 32.178
CNC: 9.682
low: 9.161
 EV/R 0.35
CAPITAL STRUCTURE
 Asset To Equity 3.679
 Asset To Liability 1.375
 Debt To Capital 0.417
 Debt To Assets 0.194
Debt To Assets QoQ -3.803 %
Debt To Assets YoY -4.64 %
Debt To Assets IPRWA high: 0.838
mean: 0.375
median: 0.301
CNC: 0.194
low: 0.006
 Debt To Equity 0.714
Debt To Equity QoQ -6.574 %
Debt To Equity YoY 11.296 %
Debt To Equity IPRWA high: 1.375
mean: 0.807
median: 0.748
CNC: 0.714
low: 0.011
PRICE-BASED VALUATION
 Price To Book (P/B) 1.318
Price To Book QoQ 48.748 %
Price To Book YoY 105.646 %
Price To Book IPRWA high: 7.829
mean: 2.092
median: 1.767
CNC: 1.318
low: -0.321
 Price To Earnings (P/E) 23.974
Price To Earnings QoQ 109.344 %
Price To Earnings YoY -126.209 %
Price To Earnings IPRWA high: 133.945
mean: 48.954
median: 45.322
CNC: 23.974
low: -16.66
 PE/G Ratio -0.939
 Price To Sales (P/S) 0.555
Price To Sales QoQ 46.0 %
Price To Sales YoY 54.013 %
Price To Sales IPRWA high: 11.857
mean: 2.384
median: 1.655
CNC: 0.555
low: 0.158
FORWARD MULTIPLES
Forward P/E 42.333
Forward PE/G -1.659
Forward P/S 3.755
EFFICIENCY OPERATIONAL
 Operating Leverage -3.789
ASSET & SALES
 Asset Turnover Ratio 0.653
Asset Turnover Ratio QoQ 3.186 %
Asset Turnover Ratio YoY 16.117 %
Asset Turnover Ratio IPRWA high: 1.051
CNC: 0.653
median: 0.419
mean: 0.417
low: 0.156
 Receivables Turnover 2.857
Receivables Turnover Ratio QoQ 7.361 %
Receivables Turnover Ratio YoY 28.935 %
Receivables Turnover Ratio IPRWA high: 7.49
mean: 3.742
median: 3.723
CNC: 2.857
low: 0.6
 Inventory Turnover
Inventory Turnover Ratio QoQ
Inventory Turnover Ratio YoY
Inventory Turnover Ratio IPRWA
 Days Sales Outstanding (DSO) 31.935
CASH CYCLE
 Cash Conversion Cycle Days (CCC) -3.834
Cash Conversion Cycle Days QoQ -178.591 %
Cash Conversion Cycle Days YoY
Cash Conversion Cycle Days IPRWA high: 133.289
median: 17.698
mean: 13.096
CNC: -3.834
low: -56.959
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 9.041
 CapEx To Revenue -0.003
 CapEx To Depreciation -1.252
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 38.6 B
 Net Invested Capital 38.7 B
 Invested Capital 38.7 B
 Net Tangible Assets 7.5 B
 Net Working Capital 5.9 B
LIQUIDITY
 Cash Ratio 0.664
 Current Ratio 1.145
Current Ratio QoQ 1.952 %
Current Ratio YoY 4.322 %
Current Ratio IPRWA high: 2.421
CNC: 1.145
mean: 1.052
median: 0.866
low: 0.846
 Quick Ratio
Quick Ratio QoQ
Quick Ratio YoY
Quick Ratio IPRWA
COVERAGE & LEVERAGE
 Debt To EBITDA 8.306
 Cost Of Debt 0.689 %
 Interest Coverage Ratio 10.712
Interest Coverage Ratio QoQ -22.367 %
Interest Coverage Ratio YoY -2193.251 %
Interest Coverage Ratio IPRWA high: 26.066
CNC: 10.712
mean: 6.327
median: 6.254
low: -4.266
 Operating Cash Flow Ratio 0.095
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 35.768
DIVIDENDS
 Dividend Coverage Ratio
 Dividend Payout Ratio
 Dividend Rate
 Dividend Yield
PERFORMANCE GROWTH
 Asset Growth Rate 2.263 %
 Revenue Growth 7.278 %
Revenue Growth QoQ 1554.091 %
Revenue Growth YoY 59.886 %
Revenue Growth IPRWA high: 9.387 %
CNC: 7.278 %
median: 3.075 %
mean: 1.519 %
low: -4.983 %
 Earnings Growth -25.519 %
Earnings Growth QoQ -93.34 %
Earnings Growth YoY -78.298 %
Earnings Growth IPRWA high: 108.333 %
median: 0.389 %
mean: -4.425 %
CNC: -25.519 %
low: -112.5 %
MARGINS
 Gross Margin 8.587 %
Gross Margin QoQ -22.834 %
Gross Margin YoY 42.028 %
Gross Margin IPRWA high: 96.512 %
mean: 28.905 %
median: 14.844 %
CNC: 8.587 %
low: 7.168 %
 EBIT Margin 3.059 %
EBIT Margin QoQ -32.487 %
EBIT Margin YoY -1818.539 %
EBIT Margin IPRWA high: 25.559 %
mean: 7.683 %
median: 4.462 %
CNC: 3.059 %
low: -4.917 %
 Return On Sales (ROS) 2.236 %
Return On Sales QoQ -39.989 %
Return On Sales YoY -370.375 %
Return On Sales IPRWA high: 23.787 %
mean: 8.646 %
median: 4.433 %
CNC: 2.236 %
low: -2.862 %
CASH FLOW
 Free Cash Flow (FCF) 3.4 B
 Free Cash Flow Yield 11.492 %
Free Cash Flow Yield QoQ -47.647 %
Free Cash Flow Yield YoY 27.945 %
Free Cash Flow Yield IPRWA CNC: 11.492 %
high: 6.209 %
mean: 2.071 %
median: 1.947 %
low: -4.3 %
 Free Cash Growth -18.003 %
Free Cash Growth QoQ -101.023 %
Free Cash Growth YoY -222.544 %
Free Cash Growth IPRWA high: 293.51 %
median: 23.352 %
mean: -17.916 %
CNC: -18.003 %
low: -438.717 %
 Free Cash To Net Income 3.131
 Cash Flow Margin 7.23 %
 Cash Flow To Earnings 3.551
VALUE & RETURNS
 Economic Value Added 0.03
 Return On Assets (ROA) 1.329 %
Return On Assets QoQ -31.916 %
Return On Assets YoY -555.137 %
Return On Assets IPRWA high: 4.836 %
mean: 1.579 %
CNC: 1.329 %
median: 1.176 %
low: 0.129 %
 Return On Capital Employed (ROCE) 3.879 %
 Return On Equity (ROE) 0.048
Return On Equity QoQ -32.759 %
Return On Equity YoY -623.944 %
Return On Equity IPRWA high: 0.177
CNC: 0.048
mean: 0.043
median: 0.037
low: -0.05
 DuPont ROE 4.96 %
 Return On Invested Capital (ROIC) 3.099 %
Return On Invested Capital QoQ -29.408 %
Return On Invested Capital YoY -2125.49 %
Return On Invested Capital IPRWA high: 7.881 %
mean: 3.372 %
CNC: 3.099 %
median: 2.555 %
low: -0.608 %

Six-Week Outlook

For swing traders: momentum favors the upside while several indicators warn of a near-term pause. A bullish MACD crossover and rising RSI support continued drift higher, but MRO’s positive reading with a peak-and-reversal and price sitting near the upper Bollinger band imply pullback risk. Directional indicators deliver offsetting signals and ADX near 21 signals only emerging strength; low volume further lowers conviction. Expect range-bound action with an upside bias unless ADX rises and volume expands to confirm follow-through; alternatively, an MRO-driven correction could produce a short consolidation before another attempt higher.

About Centene Corporation

Centene Corporation (NYSE:CNC) delivers comprehensive healthcare services, primarily targeting under-insured and uninsured populations across the United States. Established in 1984 and based in St. Louis, Missouri, Centene develops a wide array of health plans through its Medicaid, Medicare, and Commercial segments. The Medicaid segment offers expanded health plans, children’s health insurance programs, and long-term services. In the Medicare segment, Centene addresses the needs of seniors with special needs plans, Medicare supplements, and prescription drug plans. The Commercial segment provides marketplace insurance products for individuals and businesses, ensuring extensive access to healthcare services. Centene actively participates in government healthcare contracts, including the TRICARE program for military families, highlighting its dedication to diverse communities. The company also manages clinical healthcare services, pharmacies, and provides dental and speech therapy, promoting a holistic healthcare approach. By collaborating with primary and specialty care physicians, hospitals, and ancillary providers, Centene aims to deliver personalized, high-quality care to millions of Americans, emphasizing innovation and community well-being.



© 2026 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.